未登录

K

Kideok Jin

state university of new york (suny) system

H指数:20

被引数:1,638

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Crosstalk between adipocyte and tumor cells with ESR1 mutations via adipsin enhances tumor growth

CANCER RESEARCH

IF16.6

2024-05-020

PRE

The HOXB7 protein promotes breast cancer cell growth through activation of the CCL5/CCR5 pathway in the crosstalk of adipocyte

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Overview of the therapeutic strategies for ER positive breast cancer

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-06-0111

OAAI

The role of CXCL1 in crosstalk between breast cancer cells with ESR1 mutations and lymphatic endothelial cells

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Adipsin promotes tumor progression in ESR1 mutant breast cancer cells

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy

CANCER BIOLOGY & THERAPY

IF4.6

2020-03-2622

OAAI

Crosstalk between stromal components and endocrine resistant breast cancer via secreted factors enhances tumor growth and metastasis

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

BREAST CANCER RESEARCH

IF5.6

2018-06-1471

OAAI

IL-8 signaling enhances TNBC growth and metastasis via crosstalk with stromal components

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors

MOLECULAR ONCOLOGY

IF4.5

2017-04-0623

OAAI

Crosstalk between TNBC and stromal components via secreted factors enhances cell motility that can be attenuated by a CXCR1 inhibitor

CANCER RESEARCH

IF16.6

2016-07-150

PRE

The Widening Sphere of Influence of HOXB7 in Solid Tumors

CANCER RESEARCH

IF16.6

2016-05-1235

OAAI

HOX genes: Major actors in resistance to selective endocrine response modifiers

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2016-04-0120

OAAI

Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer

CANCER RESEARCH

IF16.6

2016-03-3139

OAAI

HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance

CANCER DISCOVERY

IF33.3

2015-09-0181

OAAI

HOXB7 Promotes Malignant Progression by Activating the TGFβ Signaling Pathway

CANCER RESEARCH

IF16.6

2015-02-1560

OAAI

Clonal selection in tamoxifen resistance

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-271

PREAI

Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis

NATURE COMMUNICATIONS

IF15.7

2014-09-02170

OAAI

HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression

CANCER RESEARCH

IF16.6

2013-09-0295

OAAI

HOXB7 functions as a co-activator of estrogen receptor in the development of tamoxifen resistance.

CANCER RESEARCH

IF16.6

2013-04-010

PRE